Argonaute-2 enhances suppression of human cytomegalovirus replication by polycistronic short hairpin RNAs targeting UL46, UL70 and UL122

Antiviral Therapy

Volumn 16, Issue 5, 2011, Pages 741-749

  Shao, Pei Lan ^a   Lu, Meng You ^a   Liau, Yi Jen ^a   Chao, Miau Fen ^a   Chang, Luan Yin ^a   Lu, Chun Yi ^a   Kao, Chuan Liang ^a   Chang, Shu Yuan ^a   Chi, Ya Hui ^b   Huang, Li Min ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; PLASMID VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; VIRUS ENZYME;

ANTIVIRAL THERAPY; ARTICLE; DRUG TARGETING; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; LUNG FIBROBLAST; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE; RNA SYNTHESIS; UL122 GENE; UL46 GENE; UL70 GENE; VIRUS CAPSID; VIRUS GENE; VIRUS INHIBITION; VIRUS PLAQUE; VIRUS RELEASE; VIRUS REPLICATION;

ARGONAUTE PROTEINS; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FIBROBLASTS; GENES; GENETIC VECTORS; HUMANS; IMMEDIATE-EARLY PROTEINS; MICRORNAS; MOLECULAR TARGETED THERAPY; PLASMIDS; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 80052441245     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1808     Document Type: Article

References (49)

1. Chau T.N., Lau L.K., Lee K.C., et al. Association of selflimited cytomegalovirus colitis and shigellosis in an immunocompetent patient. Eur J Gastroenterol Hepatol 1996; 8:819-822.
2. Buckner F.S., Pomeroy C. Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS. Clin Infect Dis 1993; 17:644-656. (Pubitemid 23293373)
3. Meyers J.D., Flournoy N., Thomas E.D. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153:478-488. (Pubitemid 16135651)
4. Lischka P., Zimmermann H. Antiviral strategies to combat cytomegalovirus infections in transplant recipients. Curr Opin Pharmacol 2008; 8:541-548.
5. Randolph-Habecker J., Iwata M., Torok-Storb B. Cytomegalovirus mediated myelosuppression. J Clin Virol 2002; 25 Suppl 2:S51-S56. (Pubitemid 35287191)
6. Mui T.S., Kapp M., Einsele H., Grigoleit G.U. T-cell therapy for cytomegalovirus infection. Curr Opin Organ Transplant 2010; 15:744-750.
7. Lu P.Y., Xie F., Woodle M.C. In vivo application of RNA interference: From functional genomics to therapeutics. Adv Genet 2005; 54:115-142. (Pubitemid 43583920)
8. Brodersen P., Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 2009; 10:141-148.
9. Durcan N., Murphy C., Cryan S.A. Inhalable siRNA: Potential as a therapeutic agent in the lungs. Mol Pharm 2008; 5:559-566.
10. Takeshita F., Ochiya T. Therapeutic potential of RNA interference against cancer. Cancer Sci 2006; 97:689-696. (Pubitemid 43983779)
11. Chable-Bessia C., Meziane O., Latreille D., et al. Suppression of HIV-1 replication by microRNA effectors. Retrovirology 2009; 6:26.
12. Schopman N.C., ter Brake O., Berkhout B. Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs. Retrovirology 2010; 7:52.
13. Yeung M.L., Benkirane M., Jeang K.T. Small non-coding RNAs, mammalian cells, and viruses: Regulatory interactions? Retrovirology 2007; 4:74.
14. Bennasser Y., Yeung M.L., Benkirane M., Jeang K.T. RNA interference and HIV-1: Hits and misses. Curr Opin HIV AIDS 2006; 1:208-211.
15. Svoboda P. Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr Opin Mol Ther 2007; 9:248-257. (Pubitemid 46944316)
16. Aagaard L., Rossi J.J. RNAi therapeutics: Principles, prospects and challenges. Adv Drug Deliv Rev 2007; 59:75-86. (Pubitemid 46770900)
17. Chang K., Elledge S.J., Hannon G.J. Lessons from nature: MicroRNA-based shRNA libraries. Nat Methods 2006; 3:707-714. (Pubitemid 44275738)
18. Paddison P.J., Cleary M., Silva J.M., et al. Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat Methods 2004; 1:163-167.
19. Van de Wetering M., Oving I., Muncan V., et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003; 4:609-615. (Pubitemid 36939953)
20. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009; 10:126-139.
21. Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nat Cell Biol 2009; 11:228-234.
22. Du G., Yonekubo J., Zeng Y., Osisami M., Frohman M.A. Design of expression vectors for RNA interference based on miRNAs and RNA splicing. FEBS J 2006; 273:5421-5427. (Pubitemid 44772398)
23. Chiba S., Striker R.L., Jr. yesh-Melnick M. Microculture plaque assay for human and simian cytomegaloviruses. Appl Microbiol 1972; 23:780-783.
24. Scalzo A.A., Fitzgerald N.A., Simmons A., La Vista A.B., Shellam G.R. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 1990; 171:1469-1483. (Pubitemid 20167544)
25. Wiebusch L., Hagemeier C. The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation. EMBO J 2001; 20:1086-1098. (Pubitemid 32186799)
26. Gatignol A., Buckler-White A., Berkhout B., Jeang K.T. Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 1991; 251:1597-1600. (Pubitemid 21916930)
27. Meister G., Landthaler M., Patkaniowska A., et al. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 2004; 15:185-197. (Pubitemid 38950966)
28. Silva J.M., Li M.Z., Chang K., et al. Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 2005; 37:1281-1288. (Pubitemid 41568714)
29. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 2003; 31:3406-3415. (Pubitemid 37442169)
30. Mathews D.H., Sabina J., Zuker M., Turner D.H. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 1999; 288:911-940. (Pubitemid 29248642)
31. Ge Q., Ilves H., Dallas A., et al. Minimal-length short hairpin RNAs: The relationship of structure and RNAi activity. RNA 2010; 16:106-117.
32. Shao Y., Chan C.Y., Maliyekkel A., et al. Effect of target secondary structure on RNAi efficiency. RNA 2007; 13:1631-1640. (Pubitemid 47481671)
33. Westerhout E.M., Ooms M., Vink M., Das A.T., Berkhout B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 2005; 33:796-804. (Pubitemid 40361009)
34. Diederichs S., Jung S., Rothenberg S.M., et al. Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites. Proc Natl Acad Sci U S A 2008; 105:9284-9289.
35. Grimm D., Wang L., Lee J.S., et al. Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J Clin Invest 2010; 120:3106-3119.
36. Chendrimada T.P., Gregory R.I., Kumaraswamy E., et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436:740-744. (Pubitemid 41117280)
37. Wang H.W., Noland C., Siridechadilok B., et al. Structural insights into RNA processing by the human RISC-loading complex. Nat Struct Mol Biol 2009; 16:1148-1153.
38. Wiebusch L., Truss M., Hagemeier C. Inhibition of human cytomegalovirus replication by small interfering RNAs. J Gen Virol 2004; 85:179-184. (Pubitemid 38128883)
39. Yue J., Sheng Y., Ren A., Penmatsa S. A miR-21 hairpin structure-based gene knockdown vector. Biochem Biophys Res Commun 2010; 394:667-672.
40. Lau P.W., Potter C.S., Carragher B., MacRae I.J. Structure of the human Dicer-TRBP complex by electron microscopy. Structure 2009; 17:1326-1332.
41. Cifuentes D., Xue H., Taylor D.W., et al. A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 2010; 328:1694-1698.
42. Grimm D., Kay M.A. Combinatorial RNAi: A winning strategy for the race against evolving targets? Mol Ther 2007; 15:878-888. (Pubitemid 46621646)
43. Grimm D., Kay M.A. Combinatorial RNAi: A winning strategy for the race against evolving targets? Mol Ther 2007; 15:878-888. (Pubitemid 46621646)
44. Liu Y.P., Haasnoot J., Berkhout B. Design of extended short hairpin RNAs for HIV-1 inhibition. Nucleic Acids Res 2007; 35:5683-5693. (Pubitemid 47506286)
45. Saayman S., Barichievy S., Capovilla A., et al. The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA. PLoS ONE 2008; 3:e2602.
46. Liu Y.P., Haasnoot J. ter BO, Berkhout B, Konstantinova P. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res 2008; 36:2811-2824. (Pubitemid 351737175)
47. Chattopadhyay S., Ely A., Bloom K., Weinberg M.S., Arbuthnot P. Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles. Biochem Biophys Res Commun 2009; 389:484-489.
48. Saayman S., Arbuthnot P., Weinberg M.S. Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors. Nucleic Acids Res 2010; 38:6652-6663.
49. ter Brake O., 't Hooft K., Liu Y.P., Centlivre M., Von Eije K.J., Berkhout B. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 2008; 16:557-564. (Pubitemid 351314996)